English Overview
“Beyond the Burden: A New Standard for Stable, Flare Free AD Control”, where leading dermatologists will discuss the science behind stable response in AD, and address the persistent disease burden for patients with moderate-to-severe AD.
This Activity for
- Resident / Fellow
- Physician
- Pharmacy
- Clinical Pharmacy
What I will learn?
1. Learn more about the latest efficacy data of Ebglyss, highlighting how patients maintain skin clearance and itch relief.
2. Review the clinical benefits of lebrikizumab through real-life patient cases
Activity Details
